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Neuronal diﬀerentiation in neoplasms of the central
nervous system (CNS) has been known to occur either as
a polyphenotypic trait of primitive neuroectodermal
tumors (PNET) or in the form of composite lesions
incorporating well-deﬁned neuronal and glial elements
(e.g., ganglioglioma).
Interest in the pathology of neoplasms with mixed
neuronal-glial properties has been revived in particular
by studies on the diﬀerentiation potential of central
neurocytomas [4]. On the one hand, so-called ‘‘oligo-
dendroglioma mimics’’—among them extraventricular
neurocytomas—came to be appreciated; on the other,
the issue of neuronal diﬀerentiation in bona ﬁde oligo-
dendrogliomas has been further elaborated [2]. The lat-
ter aspect recently resulted in a report by Perry et al. [6]
on four supratentorial inﬁltrative gliomas of adults with
oligodendroglial histology, evidence of neuronal immu-
nophenotype, and demonstration of co-deletions on
chromosomes 1p and 19q by ﬂuorescent in situ hybrid-
ization (FISH) analysis. A similar case was subsequently
published by Mrak et al. [5].
We recently had the opportunity to observe an
additional example of the above constellation by
studying the brain tumor from a 66-year-old female
presenting with seizures. This contrast-enhancing and
partially calciﬁed left temporal mass of 5·5·4 cm
(Fig. 1a) was removed by surgery. Histology revealed
characteristic features of a oligodendroglioma complete
with ‘‘secondary structures’’ of Scherer (i.e., perineuro-
nal satellitosis, subpial accumulation of tumor cells).
Focally brisk mitotic activity with a mean MIB-1
labeling index of near 25%, as well as microvascular
proliferation, qualiﬁed this tumor as anaplastic (WHO
grade III). Rhythmic palisades or ‘‘marching ﬁles’’ were
a prominent feature; these occasionally coalesced to
form vague neurocytic type (Homer Wright-like) ro-
settes (Fig. 1b–d). Throughout the tumor strong
immunoreactivity for synaptophysin was noted (Fig. 1e,
f). Staining for chromogranin-A and neuroﬁlament
protein, as evidence of more advanced neuronal
(gangliocytic) maturation, was absent in tumor cells.
Polyacrylamide gel electrophoresis of PCR-ampli-
ﬁed microsatellite markers revealed loss of heterozy-
gosity (LOH) on both chromosome 1p36 (D1S468,
D1S228, D1S214) and 19q13 (D19S412) in DNA
extracted from tumor tissue as compared with non-
tumorous somatic DNA obtained from a prior ton-
sillectomy specimen (Fig. 1g, h).
The genotype documented here is considered a
characteristic ‘‘molecular signature’’ of oligodendro-
gliomas, and adds further support to the existence of
neuronal diﬀerentiation within tumors that otherwise
fulﬁll accepted clinicopathological criteria of oligo-
dendroglioma. These include, among others: occur-
rence in adults, supratentorial location, overtly
inﬁltrative growth and a propensity to recur for both
low- and high-grade lesions, in contradistinction from
extraventricular neurocytomas, which are essentially, if
not exclusively, low-grade [2, 6]. Notably, the latter
Fig. 1 Native axial CT scan to show focally calciﬁed tumor in left
temporal lobe (a). Histologically, beside classic ‘‘honeycomb’’
pattern (b) and rhythmic palisades (c), some scattered groups of
neurocytic type rosettes (d) were occasionally seen. Most tumor
cells show intense positivity for synaptophysin (e). On a consec-
utive section (f), the corresponding area reveals only scant residual
neuroﬁlament-positive axons in inﬁltrated brain parenchyma.
SYBR gold-stained electrophoresis gels (Spreadex) to show loss
of microsatellite markers on chromosome 1p36 (g) and 19q13 (h) in
tumor-derived DNA versus normal somatic control (T tumor, N
normal control, s length standard). b–d Hematoxylin and eosin; e, f
immunohistochemistry. Bars 50 lm
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only seldom harbor LOH 1p/19q [7]. Although obvi-
ously rare, the ‘‘oligodendroglioma with neurocytic
diﬀerentiation’’ may evolve to a paradigm with his-
tological and genetic features that will eventually
prove reproducible enough to warrant consideration as
an emerging entity [3].
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From a practical standpoint, it is important for the
pathologist to become aware of the existence of ‘‘oligo-
dendrogliomas with neurocytic diﬀerentiation’’ so as not
to intuitively bias interpretation of synaptophysin-
immunoreactive ‘‘honeycombing’’ CNS tumors towards
either low-grade oligodendrogliomamimics, or the highly
malignant PNET.
In a more general context of CNS tumor biology, the
‘‘oligodendroglioma with neurocytic diﬀerentiation’’
further substantiates the variously perceived occurrence
of neuronal characteristics in diﬀusely inﬁltrating glio-
mas [8]. With ostensibly ‘‘composite’’ lesions (e.g., gan-
glioglioma, dysembryoplastic neuroepithelial tumor,
etc.) on one end of the spectrum, and an inﬁltrating
glioma of hybrid glial-neuronal phenotype on the other,
speculation about a purported pluripotential cell of
origin (e.g., the N-O cell) thus comes full circle [9]. Al-
though the very existence of the latter is only supported
by circumstantial evidence, neoplastic transformation of
adult neuroectodermal precursors with stem cell prop-
erties is currently being entertained as a possible source
of at least a subset of gliomas [1].
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